NINDS Advisory Council Agenda - May 18, 2017

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke

National Advisory Neurological Disorders and Stroke Council
199th Meeting

May 18, 2017
Building 35, Porter Neuroscience Research Center, Conference Room 620/630
35 Convent Drive
Bethesda, Maryland 20892
NIH Videocast Website:
 https://videocast.nih.gov/
 

AGENDA

May 18, 2017

OPEN SESSION

8:00 a.m.
I.  Call to Order and Opening Remarks
Dr. Walter Koroshetz
Chairperson
Director, NINDS

8:05 a.m.
II.  Report of the Director, Division of Extramural Research, NINDS
Dr. Robert Finkelstein
Executive Secretary, NANDS Council

A.    Consideration of Minutes of February 9, 2017, Meeting
B.    Confirmation of Dates for Future Council Meetings

September 7-8, 2017      (Thursday and Friday)
February 1-2, 2018         (Thursday and Friday)
May 24-25, 2018            (Thursday and Friday)
September 13-14, 2018  (Thursday and Friday)
 
***NEW DATES***
February 7-8, 2019         (Thursday and Friday)
May 24-25, 2019            (Thursday and Friday)
September 5-6, 2019      (Thursday and Friday)

C.   Other Items

Expedited Review Process
Extramural Announcements

 

8:15 a.m.
III.  Report of the Director, NINDS
Dr. Walter Koroshetz

 

9:15 a.m.
IV.  NeuroEthics and the BRAIN Initiative
Dr. Christine Grady
Chief, NIH Clinical Center Department of Bioethics

9:30 a.m.
V.  Concept Clearance for Proposed Initiative: Neurobiology of Small Blood and Lymphatic Vessels in Health and Disease
Dr. Francesca Bosetti
Neural Environment Cluster, NINDS

10:00 a.m. BREAK

10:15 a.m.
VI. NIH Updates
Dr. Lawrence Tabak
Principal Deputy Director, NIH

10:45 a.m.
VII. Discussion of NIH Updates
Dr. Robert Finkelstein

11:00 a.m.
VIII. Update from the Scientific Director of Intramural Research
Dr. Alan Koretsky
Scientific Director, NINDS

11:45 a.m.LUNCH

1:00 p.m.
IX. Charting Our Future Together: Setting an Agenda for the NHLBI
Dr. Gary Gibbons
Director, National Heart, Lung, and Blood Institute (NHLBI)

1:45 p.m. BREAK

2:00 p.m.
CLOSED SESSION

This portion of the meeting is being closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S. Code and Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

X. Review of Conflict of Interest, Confidentiality, and Council Procedures
Council Consideration of Pending Applications
Dr. Robert Finkelstein

4:45 p.m.
CLOSED SESSION (Continued)

This portion of the meeting is being closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S. Code and Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

XI. Review of the Division of Intramural Research Board of Scientific Counselors’ Reports
Dr. Alan Koretsky

5:10 p.m. **
ADJOURNMENT